Skip to main content
. 2023 Jul 13;11:100305. doi: 10.1016/j.rcsop.2023.100305

Table 4.

Summary of clinical pharmacist activities provided by the post-discharge clinical pharmacist in studies reporting 30-day hospital readmission and/or representations (n = 45).

Clinical pharmacist activity Significant (n = 19)a
Not significant (n = 27)a
Frequency % Frequency %
Best possible medication history 7 37 8 30
Medication reconciliation (post-discharge) 10 53 18 67
Best possible medication discharge listb 1 5 2 7
Patient educationb 10 53 19 70
Discharge medication supply 0 0 1 4
Medication order review 8 42 9 33
Pharmaceutical (or medication) review 16 84 24 89
Interventions directed to inpatient physician 2 11 1 4
Interventions directed to primary care provider 12 63 13 48
a

Rebello et al is represented as a study with both a significant (ED/urgent care visit) and not significant (30-day readmissions) outcome.

b

Provided as part of the post-discharge clinic pharmacist follow-up.